Capital Fund Management (CFM)’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-5,200
Closed -$436K – 1943
2019
Q1
$436K Buy
5,200
+3,100
+148% +$324K ﹤0.01% 1298
2018
Q4
$247K Sell
2,100
-1,200
-36% -$139K ﹤0.01% 1675
2018
Q3
$398K Sell
3,300
-800
-20% -$99.3K ﹤0.01% 1678
2018
Q2
$473K Buy
+4,100
New +$449K ﹤0.01% 1619
2015
Q2
– Sell
-4,600
Closed -$256K – 1715
2015
Q1
$256K Buy
+4,600
New +$236K ﹤0.01% 1300
2014
Q2
– Sell
-14,884
Closed -$561K – 1952
2014
Q1
$561K Buy
+14,884
New +$520K 0.01% 1195
2013
Q3
– Sell
-7,600
Closed -$275K – 1918
2013
Q2
$275K Buy
+7,600
New +$231K ﹤0.01% 1166

Other funds holding USNA

Capital Fund Management (CFM)'s USNA Position: Q2 2019 in Review

Capital Fund Management (CFM) sold out of Usana Health Sciences (USNA) in Q2 2019, closing a stake of 5,200 shares — an estimated $436K sold.

Capital Fund Management (CFM) first reported a position in USNA in Q2 2013 and held it in 7 quarters. The position peaked at $561K in Q1 2014. 173 funds tracked by Wall St. Rank hold USNA as of Q2 2019.

  • Capital Fund Management (CFM) reported no remaining Usana Health Sciences position as of Q2 2019 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 5,200 Usana Health Sciences shares in Q2 2019, an estimated $436K.
  • Capital Fund Management (CFM) first reported a position in Usana Health Sciences in Q2 2013 and held it in 7 quarters.
  • Capital Fund Management (CFM)'s Usana Health Sciences position peaked at $561K in Q1 2014.
  • 173 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2019.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2019, filed 12 Aug 2019.